TheProfitWatch

CNSP - CNS Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.55 -0.03 (-0.31%) --- --- --- --- -0.03 (-0.31%) -0.03 (-0.29%) -0.03 (-0.29%)

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-6.42
Diluted EPS:
-6.42
Basic P/E:
-1.4829
Diluted P/E:
-1.4829
RSI(14) 1m:
31.82
VWAP:
9.51
RVol:
0.211

Events

Period Kind Movement Occurred At
1m Price increase 1m 9.6 +0.1 (+1.05%) Oct 15 15:44
1m Price decrease 1m 9.31 -0.11 (-1.15%) Oct 15 10:42

Related News